Armin Karamian’s Post

Have you heard about the benefits of Oleuropein for brain health? Recent research indicates that this compound can lower inflammation and cell death in traumatic brain injury models. This discovery could pave the way for new therapeutic strategies for brain injury recovery. Let's stay informed and explore potential breakthroughs in neuroprotection! #FRI #DrKohen #NeuroProtection #BrainHealth #TraumaticBrainInjury

At the Queensland Brain Injury Collaborative (QBIC), we’re dedicated to three key aspects of acquired brain injury... 1. Stroke Our research includes improved ways to assess and diagnose deficits for more personalised treatment regimes, and new approaches to rehabilitation of movement, language, and cognition. 2. Traumatic Brain Injury We are looking at new technologies that improve rehabilitation prospects for people with traumatic brain injury (TBI) and ways to improve clinical prognostication for individualised treatment regimes. 3. Concussion Our research includes work to develop new point-of-care diagnostic tools to inform return-to-play decisions, and therapies for people with lingering symptoms. Visit our website to learn more: https://qbi.uq.edu.au/qbic #research #brain #injury #concussion #stroke

In a recent study published in BMJ Open, Dr. Nekane Romero-Garcia and colleagues explore the effects of hyperoxaemia on patients with acute brain injury (ABI). This systematic review and meta-analysis protocol aims to analyze whether high oxygen levels (hyperoxaemia) are linked to increased mortality and poor neurological outcomes in hospitalized adults with ABI. Hyperoxaemia is a subject particularly close to my heart due to its crucial implications in neurocritical care, and it was also the focus of my doctoral thesis. The significance of this research lies in the fact that previous studies have been inconclusive, often due to varying definitions of hyperoxaemia and differing study designs. This protocol could serve as a foundation for exciting future research in the field. #NeurocriticalCare #AcuteBrainInjury #Hyperoxaemia #SystematicReview #HealthcareResearch #PatientOutcomes #CriticalCareResearch #Hyperoxia

Excited to share my recent article published in Current Medical Issues! This case provided me with valuable lessons, which I believe are worth reflecting on. The patient was an adult male presenting with acute onset cerebellar dysfunction. Initially, the MRI study appeared grossly normal, and I was about to conclude the report as normal. However, before signing off, I decided to take a second look. That's when I noticed a small focus of restricted diffusion in the left lateral medulla, indicating an acute infarct—ultimately leading to the diagnosis of Wallenberg syndrome. This case serves as a reminder of the importance of thoroughly evaluating every sequence in an MRI, as if it's the first one. Sometimes, the last section of the last sequence might hold the answer! Link to the article: https://lnkd.in/gHa5KdeK #Reflections #Wallenbergsyndrome #neuroimaging #lessonsforlife #MRI

The Rossolimo's sign is a valuable neurological test used to detect issues in motor neuron pathways originating from the brain and spinal cord. It is particularly useful in diagnosing conditions such as strokes, tumors, concussions, and spinal cord compressions. The sign is elicited by tapping the tips of the toes, which causes an exaggerated flexion response in cases of upper motor neuron lesions, especially those involving the pyramidal tract. This clinical sign helps clinicians localize the affected pathways by observing positive responses in specific limbs. For instance, a positive sign in the left leg may indicate an issue in the pathway leading to the right side of the brain. Named after Grigory Ivanovich Rossolimo, who first described it in 1891, this sign is considered equivalent to the Babinski sign in indicating upper motor neuron damage. However, it's important to note that the absence of Rossolimo's sign doesn't necessarily rule out upper motor neuron damage, as other signs and symptoms may still be present Office: (734)-707-5105 Email: Info@drkeiser.com #ehlersdanlossyndrome #ehlersdanlos #eds #ehlersdanlosawareness #ehlersdanlossyndromes #ehlersdanlossyndromeawareness #pots #potstreatment #potsawareness #postcovid #posturalorthostatictachycardiasyndrome #potsie #dysautonomia #dysautonomiaawareness #dysautonomiawarrior #dysautonomiatreatment #vestibular #autonomicdysfunction #autonomicnervoussystem #ans #concussion #concussionawareness #concussiontreatment #concussions #postconcussionsyndrome #postconcussion #headinjury #braininjury #braininjuryawareness #braininjuryrehab

Check out our latest issue!

🧠 World Brain Tumor Day: Advocate for brain health and preventive measures. Prioritize early detection and care. [ World Brain Tumor Day, Brain Health, Early Detection, Preventive Care, Health Awareness, Brain Health Matters ] #WorldBrainTumorDay #BrainHealth #EarlyDetection #PreventiveCare #HealthAwareness #BrainHealthMatters

World Brain Tumor Day serves as a reminder of the importance of early detection and proactive management when it comes to brain health. It’s vital to prioritize brain health and support initiatives that advance our understanding and treatment of disorders related with brain. #PMBJP #WorldBrainTumorDay #BrainTumor #BrainCancer #Healthcare #JanAushadhi

Deep Brain Stimulation (DBS) can vastly improve the quality of life for patients with movement disorders like Parkinson’s disease, but is currently underutilised. Hear from Francesca Morgante, consultant neurologist, professor of Neurology, and the Eleanor Peel Chair for the study of Aging at St George’s University of London, and Vincent Sourdaine, Vice President of Neuromodulation, EMEA, at Boston Scientific, about the status of Parkinson’s Disease and its treatments. By examining the full procedure and how it can be optimised to accelerate planning and programming, time can be freed for both physician and patient. https://lnkd.in/dMAR3-5H #BSCEMEA

Fresh Out of the Oven! 🍲 In our latest article, we explored the use of volumetric MRI in tracking cognitive functions in cognitively normal Parkinson’s disease patients (PD-CN). Comparing 26 PD-CN patients with 26 healthy individuals, we found significant gray matter volume loss in the right putamen and left angular gyrus of PD-CN patients. Neuropsychological tests, particularly the Trail Making Test Part B, also showed reduced performance in PD-CN patients. Our findings suggest that MRI volumetric measurements, alongside cognitive tests, could help detect early cognitive impairment in PD-CN patients.🧠✨ #parkinson #cognition #mri #volumetry #Neuropsychiatrictests